Past and present

As early as 1931, the founder of cell therapy Prof. Dr. Paul Niehans found that subcutaneous fresh cell injections enhance the body’s ability to regenerate.

The concept of cell therapy is to stimulate the cell division of diseased organs through the according ingredients of healthy organs. This means that the diseased cell structures should be regenerated by biological stimulation.

As a result, a general revitalisation is triggered. Signs of ageing are mitigated or slowed down and the immune system is strengthened. The latest findings show that molecular therapy can also help in degenerative diseases such as Alzheimer’s and Parkinson’s disease, postoperative healing processes and organ damage. It ranges from chronic diseases, such as Asthma or rheumatic diseases, to circulatory disorders or skin diseases. Already Prof. Dr. Niehans realised that cells are not absorbed by the body as building blocks and fully installed, but cell contents specifically release the regenerative powers in a complicated manner. Thus, the molecular therapy is only effective to people whose body still may generate a regenerative response.

Types of Therapy:

Molecular therapy with

lyophilised cells:

One method that was developed in 1956 by the company Rheinchemie together with Prof. Paul Niehans and the company Nestlé. Thus, freeze-drying was invented which deprives the cells of water while all organelles and cell substances are retained. These cells have the advantage that they are durable and safe in many respects.

Molecular therapy with

adult stem cells:

Means that a transplantation of adult stem cells (your own or that of a donor) is carried out with the aim of healing a damaged organ or a disease. This form of treatment is currently still in an experimental stage, since it is performed (apart from the bone marrow transplantation in leukaemia) for only a few years.

Molecular therapy with

cell peptides:

Cells are disrupted by processing and the components dissolved in water. Through filtration the cell peptides are isolated and optionally standardised to the desired molecular weight. This form of therapy is indeed often called cell therapy, but it represents only a weakened form of the full cell therapy.

Molecular therapy with

fresh cells:

Hereby a method is known by which living cell material is injected into the patient, which was obtained from unborn or newborn animals. The live cells are injected within 2 hours after slaughter and can thus undergo no pharmacological safety tests. Due to concerns (among other things) about sterility the fresh cell therapy is now forbidden by law.

  • 1931Fresh Cell Therapy

    Prof. Paul Niehans discovers and develops the fresh cell therapy
  • 1956Lyophilised Cell

    Prof. Paul Niehans cooperates with Nestlé and develops with Rheinchemie the lyophilised cell
  • 1986Resistocell

    The company Cybilla develops the first drug from lyophilised cells: “Resistocell‘’
  • 2006Cordero

    Cordero GmbH & Co. KG for the in-house production of the lyophilisates and cell peptides
  • 2009Cell Immun

    Foundation of Cell Immun GmbH for the training and support of all cell therapists (nat./internat.)
  • 2012 Human Medical Days Bingen

    Start of the Annual In-House Congress “Human Medical Days Bingen“